← Back to Clinical Trials
Recruiting NCT06166433

NCT06166433 Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06166433
Status Recruiting
Phase
Sponsor George Washington University
Condition Second Hand Tobacco Smoke
Study Type INTERVENTIONAL
Enrollment 550 participants
Start Date 2025-02-01
Primary Completion 2027-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Smoke-free homes intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 550 participants in total. It began in 2025-02-01 with a primary completion date of 2027-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Tobacco use and secondhand smoke exposure represent critical health disparities in low- and middle-income countries; Armenia and Georgia represent the 11th and 6th highest smoking rates in men globally (51.5% and 55.5%, respectively), but have low rates of smoking in women (1.8% and 7.8%) and few smoke-free homes (38.6%), which can reduce secondhand smoke exposure and tobacco use rates. This study builds on ongoing collaborations between George Washington University, Emory, and national public health organizations in Armenia and Georgia and advancements in local public health infrastructure; it aims to adapt an evidence-based smoke-free home intervention for homes in Armenia and Georgia, develop capacity to deliver the intervention via local community partners and the national quitlines, and test the intervention in a hybrid effectiveness-implementation randomized clinical trial. This work will advance the knowledge base informing strategies to reduce global tobacco-related disparities, as well as the implementation and scale-out of evidence-based interventions in low- and middle-income countries.

Eligibility Criteria

Inclusion Criteria: 1. be greater than or equal to 18 years old 2. smoke in the home and have a child and-or nonsmoker in the home, or be a non-smoker and live with someone who smokes in the home 3. speak Armenian or Georgian 4. live in a selected community Exclusion Criteria: N/A

Contact & Investigator

Central Contact

Carla Berg

✉ carlaberg@gwu.edu

📞 4045585395

Frequently Asked Questions

Who can join the NCT06166433 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Second Hand Tobacco Smoke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06166433 currently recruiting?

Yes, NCT06166433 is actively recruiting participants. Contact the research team at carlaberg@gwu.edu for enrollment information.

Where is the NCT06166433 trial being conducted?

This trial is being conducted at Washington D.C., United States.

Who is sponsoring the NCT06166433 clinical trial?

NCT06166433 is sponsored by George Washington University. The trial plans to enroll 550 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology